Glucagon-Like Peptide-1. Gastrointestinal Regulatory Role in Metabolism and Motility

Vitamins and Hormones

Volumn 84, Issue C, 2010, Pages 319-329

  Hellström, Per M ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Gastrointestinal peptide hormones; Glucagon like peptide 1; Glucose disposal; Irritable bowel syndrome; Metabolic control

Indexed keywords

GLUCAGON LIKE PEPTIDE 1;

BOOK; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HUMAN; METABOLISM; PHYSIOLOGY; STOMACH EMPTYING;

GASTRIC EMPTYING; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; GLUCAGON-LIKE PEPTIDE 1; HUMANS;

EID: 78649370533     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-381517-0.00012-6     Document Type: Book

References (33)

1. Abu-Hamdah R., Rabiee A., Meneilly G.S., Shannon R.P., Andersen D.K., Elahi D. Clinical review: The extrapancreatic effects of glucagon-like peptide-1 and related peptides. J. Clin. Endocrinol. Metab. 2009, 94:1843-1852.
2. Blase E., Taylor K., Gao H.Y., Wintle M., Fineman M. Pharmacokinetics of an oral drug (acetaminophen) administered at various times in relation to subcutaneous injection of exenatide (exendin-4) in healthy subjects. J. Clin. Pharmacol. 2005, 45:570-577.
3. Blonde L., Klein E.J., Han J., Zhang B., Mac S.M., Poon T.H., Taylor K.L., Trautmann M.E., Kim D.D., Kendall D.M. Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in overweight patients with type 2 diabetes. Diabetes Obes. Metab. 2006, 8:436-447.
4. Bucinskaite V., Tolessa T., Pedersen J., Rydqvist B., Zerihun L., Holst J.J., Hellström P.M. Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat. Neurogastroenterol. Motil. 2009, 21:978. e78.
5. Christel C.M., DeNardo D.F., Secor S.M. Metabolic and digestive response to food ingestion in a binge-feeding lizard, the Gila monster (Heloderma suspectum). J. Exp. Biol. 2007, 210:3430-3439.
6. Cucchiara S., Franzese A., Salvia G., Alfonsi L., Iula V.D., Montisci A., Moreira F.L. Gastric emptying delay and gastric electrical derangement in IDDM. Diabetes Care 1998, 21:438-443.
7. Degn K.B., Brock B., Juhl C.B., Djurhuus C.B., Grubert J., Kim D., Han J., Taylor K., Fineman M., Schmitz O. Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia. Diabetes 2004, 53:2397-2403.
8. Edelman S.V., Bode B.W., Bailey T.S., Kipnes M.S., Brunelle R., Chen X., Frias J.P. Insulin pump therapy in patients with type 2 diabetes safely improved glycemic control using a simple insulin dosing regimen. Diabetes Technol. Ther. 2010, 12:627-633.
9. Edholm T., Degerblad M., Grybäck P., Hilsted L., Holst J.J., Jacobsson H., Efendic S., Schmidt P.T., Hellström P.M. Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis. Neurogastroenterol. Motil. 2010, Early View.
10. Edwards C.M., Stanley S.A., Davis R., Brynes A.E., Frost G.S., Seal L.J., Ghatei M.A., Bloom S.R. Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers. Am. J. Physiol. Endocrinol. Metab. 2001, 281:E155-E161.
11. Eng J., Andrews P.C., Kleinman W.A., Singh L., Raufman J.P. Purification and structure of exendin-3, a new pancreatic secretagogue isolated from Heloderma horridum venom. J. Biol. Chem. 1990, 265:20259-20262.
12. Eng J., Kleinman W.A., Singh L., Singh G., Raufman J.P. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J. Biol. Chem. 1992, 267:7402-7405.
13. Feinglos M.N., Saad M.F., Pi-Sunyer F.X., An B., Santiago O. Effects of liraglutide (NN2211), a long-acting GLP-1 analogue, on glycaemic control and bodyweight in subjects with type 2 diabetes. Diabet. Med. 2005, 22:1016-1023. Group, Liraglutide Dose-Response Study.
14. Gutniak M.K., Juntti-Berggren L., Hellström P.M., Guenifi A., Holst J.J., Efendic S. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas. Diabetes Care 1996, 19:857-863.
15. Gutniak M.K., Svartberg J., Hellström P.M., Holst J.J., Adner N., Ahrén B. Antidiabetogenic action of glucagon-like peptide-1 related to administration relative to meal intake in subjects with type 2 diabetes. J. Intern. Med. 2001, 250:81-87.
16. Hellström P.M., Hein J., Bytzer P., Björnsson E., Kristensen J., Schambye H. Clinical trial: The GLP-1 analogue ROSE-010 for management of acute pain in patients with irritable bowel syndrome: A randomised, placebo-controlled, double-blind study. Aliment. Pharmacol. Ther. 2009, 29:198-206.
17. Hellström P.M., Näslund E., Edholm T., Schmidt P.T., Kristensen J., Theodorsson E., Holst J.J., Efendic S. GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome. Neurogastroenterol. Motil. 2008, 20:649-659.
18. Holst J.J., Gromada J. Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans. Am. J. Physiol. Endocrinol. Metab. 2004, 287:E199-E206.
19. Horowitz M., Edelbroek M.A., Wishart J.M., Straathof J.W. Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects. Diabetologia 1993, 36:857-862.
20. Imeryüz N., Yeǧen B.C., Bozkurt A., Coşkun T., Villanueva-Peñacarrillo M.L., Ulusoy N.B. Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms. Am. J. Physiol. Gastrointest. Liver Physiol. 1997, 273:G920-G927.
21. Mudaliar S., Henry R.R. Effects of incretin hormones on beta-cell mass and function, body weight, and hepatic and myocardial function. Am. J. Med. 2010, 123:S19-S27.
22. Näslund E., Barkeling B., King N., Gutniak M., Blundell J.E., Holst J.J., Rössner S., Hellström P.M. Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int. J. Obes. Relat. Metab. Disord. 1999, 23:304-311.
23. Näslund E., Bogefors J., Skogar S., Grybäck P., Jacobsson H., Holst J.J., Hellström P.M. GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans. Am. J. Physiol. Regul. Integr. Comp. Physiol. 1999, 277:R910-R916.
24. Näslund E., Grybäck P., Backman L., Jacobsson H., Holst J.J., Theodorsson E., Hellström P.M. Distal small bowel hormones: Correlation with fasting antroduodenal motility and gastric emptying. Dig. Dis. Sci. 1998, 43:945-952.
25. Näslund E., Gutniak M., Skogar S., Rössner S., Hellström P.M. Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men. Am. J. Clin. Nutr. 1998, 68:525-530.
26. Näslund E., King N., Mansten S., Adner N., Holst J.J., Gutniak M., Hellström P.M. Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects. Br. J. Nutr. 2004, 91:439-446.
27. Philadelphia Zoo staff IUCN Red List of Threatened Species http://www.iucnredlist.org.
28. Raufman J.P. Bioactive peptides from lizard venoms. Regul. Pept. 1996, 61:1-18.
29. Tolessa T., Näslund E., Hellström P.M. The inhibitory mechanism of GLP-1, but not glucagon, on fasted gut motility is dependent on the l-arginine/nitric oxide pathway. Regul. Pept. 2001, 98:33-40.
30. Tolessa T., Gutniak M., Holst J.J., Efendic S., Hellström P.M. Glucagon-like peptide-1 retards gastric emptying and small bowel transit in the rat: Effect mediated through central or enteric nervous mechanisms. Dig. Dis. Sci. 1998, 43:2284-2290.
31. Tolessa T., Gutniak M., Holst J.J., Efendic S., Hellström P.M. Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin. J. Clin. Invest. 1998, 102:764-774.
32. Wang Z., Wang R.M., Owji A.A., Smith D.M., Ghatei M.A., Bloom S.R. Glucagon-like peptide-1 is a physiological incretin in rat. J. Clin. Invest. 1995, 95:417-421.
33. Wright R.D., Florey H.W., Sanders A.G. Observations on the gastric mucosa of reptilia. Quart. J. Exp. Physiol. 1957, 42:1-14.